Rochester Clinical Research is enrolling adults ages 18 and older for a study looking at a new treatment for people with type 2 diabetes, high blood pressure, and heart disease.
This study is enrolling at both Rochester & Buffalo locations.
Rochester Clinical Research is enrolling adults ages 18 and older for a study looking at a new treatment for people with type 2 diabetes, high blood pressure, and heart disease.
This study is enrolling at both Rochester & Buffalo locations.
The purpose of this study is to see if adding an investigational medicine to a commonly used diabetes medication may help lower the risk of serious heart problems, such as heart failure or heart-related death. Researchers will also look at how the treatment may affect blood pressure and kidney health.
This study will include regular health check-ins, lab tests, and study visits to help monitor your safety and how well the treatment is working over time.
You May Qualify if you are:
Other qualifications apply during screening.
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase […]
A clinical research study is now enrolling people who may be at higher risk for complications from the flu.
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]